Viewing Study NCT03559660


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-01-08 @ 8:23 AM
Study NCT ID: NCT03559660
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2025-06-11
First Post: 2018-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)
Sponsor: UCB Biopharma SRL
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module